Nature Reviews Cancer is a monthly review journal for researchers working on cancer. We, the editors, highlight the most exciting topics in cancer research.

Joined November 2011
1,582 Photos and videos
Our JUNE issue is now live!โ˜€๏ธ๐Ÿ‰ It features #REVIEWs on: - Balancing type I interferon signalling - Interplay between steatotic liver disease and liver cancer - KMT2C/KMT2D-COMPASS complex loss in cancer - #ExpertRecommendation on ovarian cancer ๐Ÿ“–๐Ÿ‘‡ dlvr.it/TSrBnp
1
6
5
1,509
Rare cancers remain underserved by precision oncology. In this #Comment, Gujral et al. propose that systematic, variant-level pharmacological mapping of approved kinase inhibitors can transform this gap. ๐Ÿ“– ๐Ÿ‘‡ dlvr.it/TT07T1
1
4
1,220
In this #ToolsoftheTrade article, Guangqing Lu describes the development and use of cytokine cellular locating platforms (CyCLoPs), a technology that enables visualization and tracking of cytokine signalling in vivo. ๐Ÿ“– ๐Ÿ‘‡ dlvr.it/TSyBN6
1
1,020
#ResearchHIghlight ๐Ÿšจ Hu et al. show extracellular vesicles (#EVs) from activated T cells enhance antigen presentation in tumour cells and dendritic cells, promoting immune-mediated tumour clearance ๐Ÿ“–๐Ÿ‘‡ dlvr.it/TSv4tF
4
6
1,373
Nature Reviews Cancer retweeted
๐ŸšจHot off the press ๐Ÿ‘‰Published a day after @ASCO #ASCO26 ๐Ÿ‘‰Pleased to share our comment in @NatureRevCancer @NaturePortfolio ๐Ÿ‘‰"Mutation-centric kinase drug repurposing for rare cancers" ๐Ÿ‘‰Rare cancers remain underserved by precision oncology. ๐Ÿ‘‰We propose that systematic, variant-level pharmacological mapping of approved kinase inhibitors can transform this gap into an opportunity for scalable drug repurposing ๐Ÿ‘‰Pleasure to collaborate with Dr. T. Gujral et al at @fredhutch @OncoAlert @PGrivasMDPhD @targetcancer @oncodaily @OpenMedicineHQ nature.com/articles/s41568-0โ€ฆ
1
22
61
6,297
Nature Reviews Cancer retweeted
Dr. Lan Coffman and co-authors summarize the roles of #MSCs in promoting or inhibiting carcinogenesis. They highlight emerging concepts including epigenetic reprogramming of MSCs to switch from a tumor suppressive to tumor-supportive phenotype. ๐Ÿ’ก go.nature.com/49opdO9 ๐Ÿ““: @NatureRevCancer
1
1,158
NEW content online! An adenosine derivative for the treatment of hepatocellular carcinoma dlvr.it/TSn746

7
1,316
#Review ๐Ÿšจ Emerging evidence links loss of the Y chromosome to cancer risk, progression and outcomes, highlighting its potential as a biomarker for prognosis and precision therapy. ๐Ÿ“–๐Ÿ‘‡ dlvr.it/TSn4Kw

4
16
1,814
#Review ๐Ÿšจ Lan Coffman&Co discuss the context-dependent role of mesenchymal stromal/stem cells (#MSCs) in supporting and restraining cancer growth and highlight how MSC biology can be exploited for cancer treatment. ๐Ÿ“–๐Ÿ‘‡ dlvr.it/TSm7s9
15
28
2,119
NEW content online! Beat it! dlvr.it/TSlM5m
5
881